Related Experiment Video
Updated: Jul 10, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Pediatric non-Hodgkin's lymphoma.
Thomas G Gross1, Amanda M Termuhlen
1Department of Pediatrics, The Ohio State University School of Medicine, Division of Hematology/Oncology/BMT, Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA. tgross@chi.osu.edu
Pediatric Non-Hodgkin's lymphoma (NHL) is distinct from adult cases, but modern treatments lead to over 80% long-term survival for children with this cancer.
Area of Science:
- Pediatric Oncology
- Hematology
- Cancer Research
Background:
- Non-Hodgkin's lymphoma (NHL) represents 7% of childhood cancers in the U.S., with about 1000 annual cases.
- Pediatric NHL exhibits unique characteristics in staging, histology, treatment protocols, and patient outcomes compared to adult NHL.
- High-grade histology is prevalent in over 90% of pediatric NHL cases.
Purpose of the Study:
- To review current therapeutic strategies for pediatric Non-Hodgkin's lymphoma.
- To highlight key differences between pediatric and adult Non-Hodgkin's lymphoma.
- To provide an overview of the management and prognosis of NHL in children and adolescents.
Main Methods:
- Literature review of current treatment guidelines and research for pediatric NHL.
- Comparative analysis of pediatric and adult NHL characteristics.
- Synthesis of data on treatment efficacy and patient outcomes.
Main Results:
- Modern therapeutic approaches achieve long-term event-free survival in over 80% of pediatric NHL patients.
- Significant variations exist in staging, histology, and treatment response between pediatric and adult NHL populations.
- High-grade histology is the predominant subtype in children diagnosed with NHL.
Conclusions:
- Despite differences from adult forms, pediatric Non-Hodgkin's lymphoma is highly curable with contemporary treatments.
- Understanding the unique aspects of pediatric NHL is crucial for optimizing patient care and outcomes.
- Ongoing research continues to refine treatment protocols for improved survival rates in young patients.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...